Eniola should enter on the Entrepreneurship pillar first and hardest: she is a 29-year-old Lagos-based independent researcher who, without institutional affiliation or lab funding, has singlehandedly built the computational pharmacology infrastructure — CCT model, TOPOLOGIX, IMPRINT, GATE — that Africa currently lacks, with endorsements from Berridge (Michigan), Gershman (Harvard), Daw (Princeton), and Mattar (NYU) serving as the institutional-legitimacy proxy. The CCT model's direct application to alcohol and stimulant addiction — catastrophically undertreated across Sub-Saharan Africa — must anchor all four essays: Education (knowledge built to serve a continent-scale health burden), Reconciliation (bridging the access gap between resource-rich academic centres and Africa's under-resourced independent researchers), Leadership (leading by proof-of-concept, demonstrating African scientific self-determination), and Entrepreneurship (ZYCO, TOPOLOGIX, and the pending CCT patent as concrete Africa-building artefacts). The essay on personal inner transformation is her highest risk section — she must resist the temptation to focus on technical output, and instead surface the cost, isolation, and resilience of building alone in Lagos, which is exactly the personal-growth narrative MRF's LDP is designed to continue.